White&Trust Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.38 M
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.20 Cr
- Satisfied Charges ₹ 7.06 M
- Revenue Growth 25.88%
- Profit Growth 19.99%
- Ebitda 86.97%
- Net Worth 19.32%
- Total Assets 25.86%
About White&Trust Pharmaceuticals (India)
White&Trust Pharmaceuticals (India) Private Limited (WPIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 July 2012 and has a history of 12 years and six months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.38 M.
The company currently has active open charges totaling ₹6.20 Cr. The company has closed loans amounting to ₹7.06 M, as per Ministry of Corporate Affairs (MCA) records.
Girish Lad, Vrushali Bhalerao, Sameer Bhalerao, and One other member serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2012PTC233018
-
Company No.
233018
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jul 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at White&Trust Pharmaceuticals (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Lad
|
Director | 05-Feb-2022 | Current |
|
Vrushali Bhalerao
|
Director | 29-Sep-2017 | Current |
|
Sameer Bhalerao
|
Director | 05-Jul-2012 | Current |
|
Shailesh Dhabekar
|
Director | 05-Feb-2022 | Current |
Financial Performance of White&Trust Pharmaceuticals (India).
White&Trust Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.88% increase. The company also saw a substantial improvement in profitability, with a 19.99% increase in profit. The company's net worth Soared by an impressive increase of 19.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of White&Trust Pharmaceuticals (India)?
In 2023, White&Trust Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Navitus Chemicals Private LimitedGirish Lad, Sameer Bhalerao and 1 more are mutual person
-
Stepping Stone Multitrade Llp
Vrushali Bhalerao is a mutual person
Charges (Loans)
₹62.00 M
₹7.06 M
Charges Breakdown by Lending Institutions
- Others : 6.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2023 | Others | ₹5.00 Cr | Open |
| 20 Jan 2021 | Others | ₹1.20 Cr | Open |
| 09 Oct 2014 | Uco Bank | ₹7.06 M | Satisfied |
How Many Employees Work at White&Trust Pharmaceuticals (India)?
White&Trust Pharmaceuticals (India) has a workforce of 51 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of White&Trust Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped White&Trust Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.